Hypertension Treatment in India & UAE

Specialist hypertension treatment in India from $500. Resistant hypertension, renal denervation, secondary hypertension workup at Apollo, Medanta, Fortis. Expert cardiologists and nephrologists.

Estimated cost: $500 – $2,000 · Average stay: 1–3 days

Hypertension — persistently elevated blood pressure above 130/80 mmHg — is the world's most prevalent cardiovascular risk factor, affecting over 1.3 billion people globally and responsible for more premature deaths than any other preventable condition. It is the leading risk factor for stroke (both ischaemic and haemorrhagic), heart attack, heart failure, kidney disease, and vascular dementia. Despite the availability of effective, inexpensive medications, blood pressure control rates remain dismally low worldwide — estimated at under 25% even in high-income countries.

In India, hypertension affects an estimated 28–30% of adults and is the leading contributor to the country's enormous stroke burden. In the UAE and Gulf region, hypertension prevalence exceeds 30% of adults, driven by high rates of obesity, sedentary lifestyle, excessive salt consumption, and the metabolic syndrome. Yet awareness, treatment, and control rates remain inadequate.

Specialist hypertension management is required for patients with: resistant hypertension (blood pressure above 140/90 mmHg despite three or more antihypertensive medications at appropriate doses, including a diuretic); suspected secondary hypertension (hypertension with a specific identifiable cause — renovascular disease, primary aldosteronism, phaeochromocytoma, Cushing's syndrome, obstructive sleep apnoea — that may be curable); hypertension in pregnancy (gestational hypertension, pre-eclampsia); young-onset hypertension (under 40 years with no obvious cause); and patients with hypertensive organ damage (left ventricular hypertrophy, CKD, retinopathy, peripheral arterial disease) requiring intensive management.

India's leading cardiology, nephrology, and endocrinology departments at Apollo Hospitals, Medanta – The Medicity, and AIIMS Delhi offer comprehensive secondary hypertension workup, specialist medication optimization, and — where indicated — interventional or surgical treatment of the underlying cause (renal artery stenting, adrenalectomy for primary aldosteronism, pheochromocytoma resection, renal denervation for resistant hypertension). The cost of specialist hypertension assessment and treatment in India is $500–$2,000 for initial workup — a fraction of the cost in Western healthcare systems.

What Causes Hypertension and When Does it Need Specialist Treatment?

Essential (primary) hypertension — accounting for 90–95% of all hypertension — has no single identifiable cause. It arises from an interaction between genetic susceptibility and environmental factors: excessive dietary sodium, low potassium and calcium intake, physical inactivity, obesity (particularly central adiposity), alcohol consumption, smoking, chronic stress, and aging-related arterial stiffening.

Secondary hypertension — 5–10% of all hypertension — has a specific, identifiable cause that may be treatable or even curable:

Primary Aldosteronism (Conn's Syndrome): The adrenal glands produce excess aldosterone, causing sodium retention and hypertension. Responsible for 5–10% of all hypertension (far more common than historically thought) and over 20% of resistant hypertension. Diagnosed by elevated aldosterone-to-renin ratio; confirmed by CT adrenal and adrenal vein sampling. Treated by laparoscopic adrenalectomy (if a unilateral adenoma) — curing hypertension in 40–70% of patients — or medical therapy with spironolactone/eplerenone for bilateral hyperplasia.

Renovascular Hypertension: Renal artery stenosis (most commonly from atherosclerosis or fibromuscular dysplasia) reduces kidney perfusion, activating the renin-angiotensin system and causing severe hypertension. Diagnosed by CT angiography or MRA; treated by renal artery angioplasty and stenting (for atherosclerotic stenosis above 70% with resistant hypertension or flash pulmonary oedema) or by percutaneous balloon angioplasty alone (for fibromuscular dysplasia — highly effective, often curative).

Phaeochromocytoma and Paraganglioma: Catecholamine-secreting adrenal or extra-adrenal tumors causing paroxysmal severe hypertension, palpitations, sweating, and headache. Diagnosed by 24-hour urine catecholamines/metanephrines or plasma free metanephrines; imaged by CT/MRI and functional scan (MIBG or PET). Treated by surgical excision after alpha-blockade with phenoxybenzamine.

Obstructive Sleep Apnoea (OSA): Repeated nocturnal oxygen desaturations activate the sympathetic nervous system and the renin-angiotensin system, causing resistant hypertension. Treated by CPAP — which reduces blood pressure by 2–4 mmHg on average (more in severe OSA).

Renal Parenchymal Disease: Chronic kidney disease of any cause causes hypertension through volume overload and impaired vasodilator (prostaglandin) production. Excellent blood pressure control (target 130/80 mmHg) slows CKD progression.

Who Needs Specialist Hypertension Assessment?

Specialist assessment is indicated for: resistant hypertension (BP above 140/90 mmHg on three or more drugs); young age of onset (under 40 years) without obesity or family history; hypertensive crises (BP above 180/120 mmHg) with or without target organ damage; hypertension with hypokalaemia (suggests primary aldosteronism); paroxysmal hypertension with headache and palpitations (phaeochromocytoma); reduced kidney perfusion on imaging; and pregnancy-associated hypertension.

Patients who have not reached BP target on two or more medications (pseudo-resistant hypertension due to poor adherence is first excluded) benefit from secondary cause evaluation and expert medication optimization.

Hypertension Treatment Approaches

Treatment of hypertension is highly individualized based on the stage of hypertension, cardiovascular risk profile, comorbidities, and the presence or absence of a secondary cause.

Lifestyle Intervention: DASH diet (reduced sodium under 2g/day, high fruits/vegetables, low fat dairy), weight reduction (each kg of weight loss reduces systolic BP by 1 mmHg), aerobic exercise (5 sessions/week of 30 minutes moderate intensity reduces SBP by 4–8 mmHg), alcohol reduction (under 14 units/week), and smoking cessation are the evidence-based non-pharmacological measures.

Medical Therapy: First-line agents for most patients: ACE inhibitors (ramipril, lisinopril) or ARBs (losartan, olmesartan, telmisartan); calcium channel blockers (amlodipine, lercanidipine); and thiazide-type diuretics (indapamide, chlortalidone). For most patients with stage 2 hypertension (above 150/90 mmHg), combination therapy from initiation is more effective and better tolerated than sequential monotherapy. Single-pill combination (SPC) tablets significantly improve adherence. Beta-blockers are used when there is concurrent heart failure, angina, or atrial fibrillation. Spironolactone is the most effective fourth agent for resistant hypertension.

Secondary Causes: Treated specifically as described (adrenalectomy for Conn's, renal artery intervention, CPAP for OSA, pheochromocytoma excision).

Renal Denervation: An emerging catheter-based procedure for resistant hypertension — radiofrequency or ultrasound energy is delivered to the renal artery wall to disrupt sympathetic nerve fibers that contribute to blood pressure elevation. Recent SPYRAL and RADIANCE randomized trials confirm BP reduction of 5–10 mmHg systolic. FDA-approved (Recor Medical Paradise system); now available at select Indian centers.

Procedure Steps

1. Full hypertension assessment: clinic and home/ambulatory blood pressure measurement (24-hour ABPM); heart rate; BMI; waist circumference.
2. Basic investigations: blood glucose, HbA1c, lipid profile, serum sodium, potassium, creatinine, eGFR, uric acid; urine albumin-to-creatinine ratio; ECG.
3. Secondary cause screening (if indicated): aldosterone-to-renin ratio (for primary aldosteronism); 24-hour urine metanephrines (phaeochromocytoma); thyroid function; renal artery duplex (renovascular); sleep study (OSA).
4. Cardiovascular risk stratification: SCORE2 or ASCVD risk score; echocardiogram for LV hypertrophy; fundoscopy for hypertensive retinopathy.
5. Lifestyle counselling: structured session with dietitian (DASH diet, sodium restriction); exercise prescription; smoking cessation support.
6. Medical therapy initiation/optimization: start or uptitrate appropriate antihypertensive regimen; preferably SPC for adherence.
7. Resistant hypertension assessment: confirm pseudo-resistance (adherence check by urine drug metabolites); rule out white-coat effect (ABPM); add spironolactone 25–50 mg.
8. Secondary cause-specific treatment: adrenal vein sampling (if ARR positive); renal artery imaging; sleep study; surgical or interventional referral as appropriate.
9. Follow-up: BP review at 4–8 weeks after initiation; annual comprehensive reassessment; home BP monitoring device provided.

Cost Comparison Worldwide

Country — Range — Savings

--- — --- — ---

United States — $3,000 – $10,000 (specialist workup) — Baseline

United Kingdom — $2,000 – $6,000 — ~40% savings vs. USA

India — $500 – $2,000 — Up to 83% savings vs. USA

UAE — $1,000 – $4,000 — ~65% savings vs. USA

Hypertension assessment packages in India include specialist cardiology or nephrology consultation, full biochemical panel, aldosterone-renin ratio, 24-hour ambulatory blood pressure monitoring (ABPM), echocardiogram, renal artery Doppler, and structured medication plan. Confirmatory tests (adrenal vein sampling, CT adrenals, MRA renal arteries, phaeochromocytoma imaging) are individually priced at very affordable rates compared to Western equivalents.

Recovery & Follow-up

Hypertension is managed chronically — there is no single "treatment" with a defined recovery. Lifestyle changes show measurable BP reduction within 2–4 weeks. Medical therapy typically reduces BP within 2–4 weeks of initiation; full effect may take 4–8 weeks. After treatment of a secondary cause (adrenalectomy, renal artery angioplasty), BP may normalize completely or partially over weeks to months.

Long-term management requires lifelong attention. Most patients with essential hypertension require indefinite medical therapy — hypertension rarely resolves spontaneously in adults. Home blood pressure monitoring (twice daily, morning and evening, 3 days before each clinic appointment) empowers patients to track their own control and identify white-coat versus true uncontrolled hypertension.

Recovery Tips

• Take blood pressure medications at the same time every day — consistency is critical for stable control.
• Measure your own blood pressure at home using a validated upper arm monitor (not wrist devices).
• Reduce sodium intake to under 2,000 mg per day — the single most effective dietary measure.
• Exercise 150 minutes of moderate aerobic activity weekly — reduces SBP by 4–8 mmHg.
• Report headache, visual disturbance, or chest pain with high BP readings — these may indicate hypertensive urgency.
• Do not stop medications without medical advice — abrupt cessation can cause hypertensive rebound.

Risks & Complications

Untreated hypertension carries the highest cardiovascular risk. Each 20 mmHg reduction in systolic BP from a starting point of 160 mmHg halves the risk of stroke and reduces heart attack risk by 40%. Medication side effects include: ACE inhibitor cough (10–15% — switch to ARB); CCB ankle swelling (5–10%); diuretic hyponatraemia and hypokalaemia (monitor electrolytes); and spironolactone gynaecomastia in men (5–10%, switch to eplerenone). Most side effects resolve with medication adjustment.

Why GAF Healthcare

Gaf Healthcare coordinates specialist hypertension assessment at India's and UAE's leading cardiology and nephrology centers. We arrange the full secondary hypertension workup — aldosterone-renin ratio, adrenal imaging, renal artery Doppler, 24-hour ABPM, and phaeochromocytoma screening — in a structured 2–3 day assessment program. You return home with a detailed, evidence-based management plan and the option of telemedicine follow-up with the specialist.

Frequently Asked Questions

What is resistant hypertension?

Resistant hypertension is defined as blood pressure above 140/90 mmHg despite taking three or more antihypertensive medications at appropriate doses, including a diuretic. True resistant hypertension (after excluding poor adherence and white-coat effect) requires specialist investigation to identify a secondary cause and optimize therapy.

Can hypertension be cured?

Essential hypertension usually requires lifelong medication. However, secondary hypertension from specific causes can be cured or dramatically improved: primary aldosteronism treated by adrenalectomy cures hypertension in 40–70% of cases; fibromuscular dysplasia renal artery angioplasty cures hypertension in 50–60%; and pheochromocytoma surgery is curative in virtually all cases.

What is renal denervation for hypertension?

Renal denervation is a catheter-based procedure where radiofrequency or ultrasound energy is delivered to the renal arteries to disrupt sympathetic nerves contributing to blood pressure elevation. Recent trials show 5–10 mmHg systolic BP reduction in resistant hypertension patients with good medication adherence. It is now FDA-approved and available at select centers in India.